The NCDR Left Atrial Appendage Occlusion Registry | JACC: Journal of the American College of Cardiology https://t.co/jddVSIQHZj
#Epeeps Two previous concerns of LAAO appear to have been allayed: 1. Absence of large unbiased (industry-independent) registries 2. Lower volume operators/ real life data may result in high complication rates https://t.co/PCKGnaEKJv
RT @bernardowise: The LAAO Registry has enrolled >38,000 patients implanted with an atrial appendage ocludder. Patients were generally olde…
The LAAO Registry has enrolled >38,000 patients implanted with an atrial appendage ocludder. Patients were generally older with more comorbidities; however, major adverse event rates were lower. #Stroke #EPeeps https://t.co/htz5UC7Isp
RT @JACCJournals: In its first three years, the #NCDR LAAO Registry enrolled >38k patients w/ the Watchman #cvLAAoccluder. Patients had low…
RT @JACCJournals: In its first three years, the #NCDR LAAO Registry enrolled >38k patients w/ the Watchman #cvLAAoccluder. Patients had low…
In its first three years, the #NCDR LAAO Registry enrolled >38k patients w/ the Watchman #cvLAAoccluder. Patients had lower in-hospital adverse event rates, compared to those in pivotal trials. Explore the data first presented at #ACC20/#WCCardio in #JA
The NCDR Left Atrial Appendage Occlusion Registry https://t.co/a3Gqi6zvuO
The NCDR Left Atrial Appendage Occlusion Registry | JACC: Journal of the American College of Cardiology https://t.co/B0LX8VYP0h
RT @JACCJournals: To better understand use of #cvLAAoccluder, @ACCinTouch & @SCAI collaborated w/ the FDA, CMS & @BostonSci to develop the…
RT @mattaustein: LAAC in the real-world... like in most trials vs real life... patients are older... sicker... but surprisingly, higher suc…
LAAC in the real-world... like in most trials vs real life... patients are older... sicker... but surprisingly, higher success rates... good job #EPeeps
RT @JonPicciniSr: Big results from Dr Jim Freeman @YaleMedicine RE #LAAO in US (n=38,158) mean age 76, CHADSVASc 4.6, & HASBLED 3, 98% w/ <…
RT @dngibson2: The NCDR Left Atrial Appendage Occlusion Registry | JACC: Journal of the American College of Cardiology. 37K patients from N…
RT @dngibson2: The NCDR Left Atrial Appendage Occlusion Registry | JACC: Journal of the American College of Cardiology. 37K patients from N…
RT @gregorymmarcus: Strong work, great foresight, and congrats @jfreeMD @PaulVarosy @Dr_BowTie65 No doubt many valuable contributions to co…
RT @dngibson2: The NCDR Left Atrial Appendage Occlusion Registry | JACC: Journal of the American College of Cardiology. 37K patients from N…
RT @dngibson2: The NCDR Left Atrial Appendage Occlusion Registry | JACC: Journal of the American College of Cardiology. 37K patients from N…
RT @dngibson2: The NCDR Left Atrial Appendage Occlusion Registry | JACC: Journal of the American College of Cardiology. 37K patients from N…
RT @dngibson2: The NCDR Left Atrial Appendage Occlusion Registry | JACC: Journal of the American College of Cardiology. 37K patients from N…
Strong work, great foresight, and congrats @jfreeMD @PaulVarosy @Dr_BowTie65 No doubt many valuable contributions to come. @ACCinTouch @ACCmediacenter
The NCDR Left Atrial Appendage Occlusion Registry | JACC: Journal of the American College of Cardiology. 37K patients from NCDR registry. Higher chads vasc than clinical trials. Higher success and lower complication rates c/w IDE trials. https://t.co/uJ
RT @JonPicciniSr: Big results from Dr Jim Freeman @YaleMedicine RE #LAAO in US (n=38,158) mean age 76, CHADSVASc 4.6, & HASBLED 3, 98% w/ <…
RT @JonPicciniSr: Big results from Dr Jim Freeman @YaleMedicine RE #LAAO in US (n=38,158) mean age 76, CHADSVASc 4.6, & HASBLED 3, 98% w/ <…
RT @JonPicciniSr: Big results from Dr Jim Freeman @YaleMedicine RE #LAAO in US (n=38,158) mean age 76, CHADSVASc 4.6, & HASBLED 3, 98% w/ <…
RT @JonPicciniSr: Big results from Dr Jim Freeman @YaleMedicine RE #LAAO in US (n=38,158) mean age 76, CHADSVASc 4.6, & HASBLED 3, 98% w/ <…
RT @JonPicciniSr: Big results from Dr Jim Freeman @YaleMedicine RE #LAAO in US (n=38,158) mean age 76, CHADSVASc 4.6, & HASBLED 3, 98% w/ <…
RT @JonPicciniSr: Big results from Dr Jim Freeman @YaleMedicine RE #LAAO in US (n=38,158) mean age 76, CHADSVASc 4.6, & HASBLED 3, 98% w/ <…
RT @JonPicciniSr: Big results from Dr Jim Freeman @YaleMedicine RE #LAAO in US (n=38,158) mean age 76, CHADSVASc 4.6, & HASBLED 3, 98% w/ <…
RT @JonPicciniSr: Big results from Dr Jim Freeman @YaleMedicine RE #LAAO in US (n=38,158) mean age 76, CHADSVASc 4.6, & HASBLED 3, 98% w/ <…
Big results from Dr Jim Freeman @YaleMedicine RE #LAAO in US (n=38,158) mean age 76, CHADSVASc 4.6, & HASBLED 3, 98% w/ <5 mm leak, & 2.16% in-hospital MAE . Patients sicker than pivotal clinical trials #Epeeps @Dr_BowTie65 @dslotwin @PaulVarosy
To better understand use of #cvLAAoccluder, @ACCinTouch & @SCAI collaborated w/ the FDA, CMS & @BostonSci to develop the #NCDR LAAO Registry. This #JACC SimPub reviews procedural outcomes during the registry's first three years. https://t.co/1liLtL